Title
Category
Credits
Event date
Cost
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
$0.00
While a substantial body of research demonstrates the need to address the global epidemic of metabolic syndrome, and the constellation of associated cardiometabolic risk factors simultaneously, the majority of them are still treated as separate entities.The engaging and interactive session recordings from this Masterclass cover experts across specialties on the current state of affairs and advances in cardiometabolic disease including team based-care, telemedicine, cardio-renal risk reduction, obesity management, and much more.
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
$0.00
The increasing rates of obesity, diabetes, and metabolic syndrome in the United States are leading to more cases NAFLD and NASH, which are now being encountered at a greater frequency in clinical practice. NASH can lead to significant morbidity and mortality, including liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC)—in fact, HCC caused by NASH is poised to become the leading cause of liver transplants in the US.
  • LivDerm
  • TME
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
Psoriasis is a chronic and inflammatory skin disease with potential systemic implications that affects 7.5 million people in the United States (Bhushan 2016; Soleymani 2018) that can lead to several comorbidities, including psoriatic arthritis, obesity, metabolic syndrome, and cardiovascular disease (Soleymani 2018). Early diagnosis and treatment are crucial in managing PsA, and clinicians need to understand the impact of both skin and joint aspects of psoriasis and PsA in order to minimize impact on patients’ quality of life (QOL).
  • LivDerm
  • TME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
This course will provide you with valuable updates in atopic dermatitis presented at the 29th Annual Masters of Pediatric Dermatology and the 19th Annual South Beach Symposium.
  • LivDerm
  • TME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
This course will provide you with valuable updates in psoriasis presented at the 29th Annual Masters of Pediatric Dermatology and the 19th Annual South Beach Symposium.
  • LivDerm
  • TME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
Acne is a chronic and inflammatory skin disorder that affects up to 50 million individuals in the United States and is one of the most common dermatologic conditions in children and adolescents (Lim 2017; Nagler 2016). Acne is characterized by noninflammatory lesions (open and closed comedones) and inflammatory lesions (papules, pustules, and nodules). The pathogenic mechanisms include microbial colonization with Propionibacterium acnes (P acnes), sebum production, inflammatory mechanisms, and follicular hyperkeratinization (Eichenfield 2013).
  • LivDerm
  • TME
  • AAPA Category I CME
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
There are gaps in dermatologic care today concerning patients with skin of color (SOC) that need to be addressed through education and putting new knowledge into practice. Patients with SOC can be disproportionately affected by dermatologic conditions such as melasma, acne, rosacea, and hyperpigmentation. Even children with SOC can be more susceptible or have a greater disease burden, especially with conditions such as acne, vitiligo, atopic dermatitis, keloids, pityriasis alba, and traction alopecia.
  • LivDerm
  • TME
  • AAPA Category I CME
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
The increasing incidence of Atopic dermatitis (AD) and poor recognition of the disease in some patient groups is a public health concern. AD symptoms and its daily management cause significant effects on quality of life for both patients and caregivers. AD is associated with an increase in other atopic manifestations as well as with serious comorbidities that can greatly affect overall patient health and wellbeing (Silverberg 2015; Simpson 2012; Yu 2016; Zheng 2011).
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
$0.00
Metabolic syndrome and associated comorbidities, such as cardiovascular disease, obesity and type 2 diabetes, are becoming more common in women of reproductive age and beyond. In addition to traditional cardiometabolic risk factors, additional risk factors, including pregnancy-related outcomes, gestational diabetes mellitus, polycystic ovary syndrome, and hormonal replacement therapy, confer important implications on women's cardiometabolic health across the lifespan.
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
Iron deficiency (ID) affects up to one-third of the world's population and is particularly common in elderly individuals and those with heart failure (HF). Many of those affected are unaware of ID and cannot recognize its symptoms. For patients with HF, ID is an independent predictor of outcomes and a major contributor to exercise intolerance. At least half of all patients with HF have comorbid ID; yet, the condition is under-recognized and untreated in most patients.

Pages